Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors

Molecular and Cellular Neuroscience

Volumn 18, Issue 1, 2001, Pages 80-90

  Hartmann, Annette M ^a,b   Rujescu, Dan ^b   Giannakouros, Thomas ^c   Nikolakaki, Eleni ^c   Goedert, Michel ^d   Mandelkow, Eva Maria ^e   Gao, Qing Sheng ^f   Andreadis, Athena ^f   Stamm, Stefan ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHOTRANSFERASE; PROTEIN CDC2; PROTEIN CLK1; PROTEIN CLK2; PROTEIN CLK3; PROTEIN CLK4; TAU PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 17; CONTROLLED STUDY; EMBRYO; EXON; FRONTOTEMPORAL DEMENTIA; GENE CASSETTE; GENE CONTROL; GENE MUTATION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PARKINSONISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; RECEPTOR UPREGULATION;

MAMMALIA;

EID: 0034916318     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2001.1000     Document Type: Article

References (98)

1. Structure and novel exons of the human tau gene
2. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: Evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart
3. A differentially expressed murine RNA encoding a protein with similarities to two types of nucleic acid binding motifs
4. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
5. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors
6. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
7. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
8. SRKP1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors
9. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution
10. The regulation of splice-site selection, and its role in human disease
11. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
12. Control of pre-mRNA processing by extracellular signals: From molecular mechanisms to clinical applications
13. Normal and pathological tau proteins as factors for microtubule assembly
14. Characterization of pathologies in transgenic mice over-expressing human genomic and cDNA tau transgenes
15. The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing
16. Splicing and the single cell
17. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides
18. The superfamily of arginine/serine-rich splicing factors
19. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A
20. Myosin light-chain 1/3 gene alternative splicing: cis regulation is based upon a hierarchical compatibility between splice sites
21. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia
22. Going new places using an old MAP: Tau, microtubules and human neurodegenerative disease
23. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
24. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
25. Biochemical mechanism of constitutive and regulated pre-mRNA splicing
26. 5′ Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
27. A serine kinase regulates intracellular localization of splicing factors in the cell cycle
28. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors
29. cis-elements involved in alternative splicing in the rat beta-tropomyosin gene: The 3′-splice site of the skeletal muscle exon 7 is the major site of blockage in nonmuscle cells
30. Altered microtubule organization in small-calibre axons of mice lacking tau protein
31. fyn
32. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
33. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
34. Common themes in the function of transcription and splicing enhancers
35. Tau consists of a set of proteins with repeated C-terminal microtubule binding domains and variable N-terminal domains
36. Htra2-beta1 stimulates an exonic splicing enhancer an can restore full-length SMN expression to survival of motor neuron 2 (SMN2)
37. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
38. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice
39. Initial sequencing and analysis of the human genome
40. Regulated expression and RNA processing of transcripts from the SRp20 splicing factor gene during the cell cycle
41. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation
42. Cell type specific expression of hnRNP proteins
43. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing
44. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells
45. Developmentally regulated expression of specific tau sequences
46. The structure and function of proteins involved in mammalian pre-mRNA splicing
47. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
48. Control of alternative splicing by the binding of U1 small nuclear ribonucleoprotein particle
49. The tangled tale of tau
50. Tau in Alzheimer's disease
51. SR proteins and splicing control
52. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF
53. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
54. Frequent alternative splicing of human genes
55. Cell biology of transcription and pre-mRNA splicing: Nuclear architecture meets nuclear function
56. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo
57. The dynamics of a pre-mRNA splicing factor in living cells
58. Intron recognition comes of AGe
59. Regulation of fibronectin EDA exon alternative splicing: Possible role of RNA secondary structure for enhancer display
60. Construction of a novel database containing aberrant splicing mutations of mammalian genes
61. p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease
62. Human transformer-2-beta gene: Complete nucleotide sequence, chromosomal localization and generation of a tissue specific isoform
63. The cellular localization of the murine serine/arginine-rich protein kinase CLK2 is regulated by serine 141 autophosphorylation
64. Characterization and comparison of four SR protein kinases
65. SAF-B couples transcription and pre-mRNA splicing to SAR/MAR elements
66. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations
67. SRPK1 and LBR protein kinases show identical substrate specificities
68. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
69. RNA processing and human disease
70. A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing
71. Tau is a candidate gene for chromosome 17 frontotemporal dementia
72. The protein kinase Clk/Sty directly modulates SR protein activity: Both hyper- and hypophosphorylation inhibit splicing
73. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis
74. The mammalian homolog of suppressor-of-white-apricot regulates alternative messenger-RNA splicing of cd45 exon-4 and fibronectin iiics
75. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake
76. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors
77. Tau protein pathology in neurodegenerative diseases
78. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
79. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
80. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies
81. Clathrin light chain B: Gene structure and neuron-specific splicing
82. Regulation of the neuron-specific exon of clathrin light chain B
83. A sequence compilation and comparison of exons that are alternatively spliced in neurons
84. An alternative exon database (AEDB) and its statistical analysis
85. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations
86. Misregulation of pre-mRNA splicing that causes human diseases
87. The in vivo minigene approach to analyze tissue-specific splicing
88. Determinants of SR protein specificity
89. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b gene
90. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
91. SRPK2: A differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells
92. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways
93. Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau
94. The role of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism
95. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides
96. Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors
97. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing
98. Distinct functions of SR proteins in alternative pre-mRNA splicing